Injectable semaglutide, sold by Novo Nordisk under the brand name Wegovy for weight loss, and tirzepatide, sold by Eli Lily as Zepbound for weight loss, generally cap out at a 15-20% body weight loss for the highest doses and 5-10% on the lower end
ELISA-based assays are less sensitive and prone to cross-reactivity with degradation products, potentially overestimating how long functional peptide remains
At NeoPredics AG, we believe predictive clinical decision support can help provide clinicians with meaningful information earlier in pregnancy, supporting more informed decision making and, ultimately, better outcomes for mothers and babies
Contact Details Name - Zoic Cosmetics
Thus, we modified GEP44 with the intent of also reducing its capacity to induce internalization at the GLP-1R